Can the 'love hormone' calm anxiety in diabetes insipidus patients?

NCT ID NCT06036004

First seen Jan 09, 2026 · Last updated Apr 24, 2026 · Updated 12 times

Summary

This study tests whether a nasal spray containing oxytocin can help reduce anxiety and improve how people with central diabetes insipidus recognize emotions in others. About 112 adults with the condition and high anxiety levels will receive either oxytocin or a placebo spray for several weeks. The goal is to see if this hormone replacement can ease psychological symptoms beyond standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL DIABETES INSIPIDUS (CDI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Erasmus University Medical Center Rotterdam

    NOT_YET_RECRUITING

    Rotterdam, 3015, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Basel, Department of Endocrinology, Diabetes & Metabolism

    RECRUITING

    Basel, 4031, Switzerland

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.